Sana Biotechnology (NASDAQ: SANA)
$9.09
(4.2%)
$0.37
Price as of April 29, 2024, 1:54 p.m. ET
Sana Biotechnology Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Sana Biotechnology Company Info
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
News & Analysis
Featured Article
2 Growth Stocks That Jumped 42% and 58% Last Week: Can They Still Climb Higher?
Good news drove shares of these stocks through the roof last week, but investors should be more concerned about their paths forward.
Cory Renauer | Apr 17, 2023
Featured Article
Why Shares of Sana Biotechnology Jumped This Week
The company announced details of research on two of its pre-clinical therapies.
Jim Halley | Apr 14, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.